Drugs / Peripheral Blood Stem Cell Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04224558 | Nov 2019 → Sep 2027 expected | Crohn disease | Cedars-Sinai Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peripheral Blood Stem Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04224558 ↗ |
| Modality | Cell therapy | “blood stem cells that have been taken from the patient's own body” NCT04224558 ↗ |